HK2 and colorectal carcinoma: Kaempferol concurrently downregulates HK2 protein expression, inhibiting the uptake of glucose by colorectal cancer (CRC) cells and consequently decreasing the levels of the HBP pathway substrate UDP-GlcNAc.